- $79.26m
- $15.26m
- $102.88m
- 91
- 95
- 22
- 79
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.47 | ||
| Price to Tang. Book | 0.49 | ||
| Price to Free Cashflow | 9.76 | ||
| Price to Sales | 0.78 | ||
| EV to EBITDA | 0.81 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 6.19% | ||
| Return on Equity | 4.38% | ||
| Operating Margin | 11.93% | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 85.69 | 89.93 | 97.59 | 98.65 | 102.88 | n/a | n/a | 3.36% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -46.85 | +22.91 | +21.03 | -24.55 | +15.67 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
FONAR Corporation is engaged in the research, development, production and marketing of medical scanning equipment, which uses principles of Magnetic Resonance Imaging (MRI) for the detection and diagnosis of human diseases. The Company conducts its business in two segments: medical equipment, and physician management and diagnostic services. Its medical equipment segment is conducted directly through the Company. Its physician management and diagnostic services segment is conducted through its subsidiary, Health Management Corporation of America (HMCA). Its signature product is the FONAR UPRIGHT Multi-Position MRI (STAND-UP MRI). HMCA provides management services, administrative services, billing and collection services, compliance consulting, purchasing, information technology (IT) services, repair, maintenance service, and clerical and other non-medical personnel to medical providers engaged in diagnostic imaging. HMCA owns and operates six diagnostic imaging facilities in Florida.
Directors
- Raymond Damadian CHM (85)
- Timothy Damadian PRE (57)
- Luciano Bonanni COO (66)
- Claudette Chan SEC (83)
- John Collins DRC
- Ronald Lehman IND (45)
- Charles O'Data IND (85)
- Richard Turk IND (37)
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- July 17th, 1978
- Public Since
- October 26th, 1981
- No. of Shareholders
- 978
- No. of Employees
- 520
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
NASDAQ Capital Market- Shares in Issue
- 6,593,850
- Address
- 110 Marcus Dr, MELVILLE, 11747-4228
- Web
- https://www.fonar.com/
- Phone
- +1 6316942929
- Contact
- Daniel Culver
- Auditors
- Marcum LLP
Upcoming Events for FONR
Fonar Corp Annual Shareholders Meeting
Fonar Corp Annual Shareholders Meeting
Q4 2025 Fonar Corp Earnings Release
Q4 2025 Fonar Corp Earnings Release
Similar to FONR
Accelerate Diagnostics
NASDAQ Capital Market
Adagio Medical Holdings
NASDAQ Capital Market
Adapthealth
NASDAQ Capital Market
Aethlon Medical
NASDAQ Capital Market
Agape ATP
NASDAQ Capital Market
FAQ
What is the Fonar share price?
As of Today at 20:40 UTC, shares in Fonar are trading at $12.02. This share price information is delayed by 15 minutes.
How has the Fonar share price performed this year?
Shares in Fonar last closed at $12.02 and the price had moved by -28.71% over the past 365 days. In terms of relative price strength the Fonar share price has underperformed the S&P500 Index by -34.19% over the past year.
What are the analyst and broker recommendations for Fonar?
There is no consensus recommendation for this security.
Find out moreWhat is the Fonar dividend yield?
Fonar does not currently pay a dividend.
Does Fonar pay a dividend?
Fonar does not currently pay a dividend.
When does Fonar next pay dividends?
Fonar does not currently pay a dividend.
How do I buy Fonar shares?
To buy shares in Fonar you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Fonar?
As of the previous close price of $12.02, shares in Fonar had a market capitalisation of $79.26m.
Where are Fonar shares listed?
Here are the trading details for Fonar:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: FONR
What kind of share is Fonar?
Based on an overall assessment of its quality, value and momentum Fonar is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Fonar share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Fonar share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Fonar. Over the past six months, its share price has underperformed the S&P500 Index by -16.76%.
As of the last closing price of $12.02, shares in Fonar were trading -22.81% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Fonar PE Ratio?
The Fonar PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $12.02.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Fonar?
Fonar's management team is headed by:
- Raymond Damadian - CHM
- Timothy Damadian - PRE
- Luciano Bonanni - COO
- Claudette Chan - SEC
- John Collins - DRC
- Ronald Lehman - IND
- Charles O'Data - IND
- Richard Turk - IND